UK markets closed

OncoZenge AB (publ) (8LY.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2825-0.0135 (-4.56%)
At close: 08:04AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-14,221
-15,902
-46,646
-3,886
-636
Depreciation & amortisation
-
-
23,168
0
0
Stock-based compensation
-
0
296
0
-
Change in working capital
-477
-1,181
-1,973
127
800
Other working capital
-14,698
-17,083
-22,078
-10,123
-1
Net cash provided by operating activities
-14,698
-17,083
-22,078
-4,767
-1
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-5,356
-
Other investing activities
-
570
-
-
-
Net cash used for investing activities
570
570
0
-5,356
0
Net change in cash
-14,128
-16,513
-22,078
41,219
9,999
Cash at beginning of period
23,790
29,140
51,218
9,999
0
Cash at end of period
9,662
12,627
29,140
51,218
9,999
Free cash flow
Operating cash flow
-14,698
-17,083
-22,078
-4,767
-1
Capital expenditure
-
-
-
-5,356
-
Free cash flow
-14,698
-17,083
-22,078
-10,123
-1